Publication | Closed Access

Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction

Regenerative MedicineCell TherapyCardiovascular Translational ResearchCardiovascular DiseaseClinical TrialsPlacebo-controlled TrialMedicineCardiologyAcute Myocardial InfarctionMyocardial Infarction